ScholarIQanswers from OpenAlex & ORCID
Shaji Kumar
ResearcherPublications, citations & collaboration network
Shaji Kumar is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Shaji Kumar have?
ScholarIQindexed works
Shaji Kumar has 2,210 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Shaji Kumar have?
ScholarIQcitation count
Shaji Kumar has 96,420 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Shaji Kumar?
ScholarIQh-index
Shaji Kumar has an h-index of 138 in OpenAlex.
What is the i10-index of Shaji Kumar?
ScholarIQi10-index
Shaji Kumar has an i10-index of 900 in OpenAlex.
What is the ORCID of Shaji Kumar?
ScholarIQorcid
The ORCID for Shaji Kumar is on the source record.
What is the OpenAlex record for Shaji Kumar?
ScholarIQopenalex
The OpenAlex for Shaji Kumar is on the source record.
What are the most-cited papers on Shaji Kumar?
ScholarIQmost cited works
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C. Anderson, Brian G.M. Durie, Ola Landgren, Philippe Moreau, Nikhil C. Munshi, Sagar Lonial, Joan Bladé, María‐Victoria Mateos, Meletios Α. Dimopoulos, Efstathios Kastritis, Mario Boccadoro, Robert Z. Orlowski, Hartmut Goldschmidt, Andrew Spencer, Jian Hou, Wee Joo Chng, Saad Z. Usmani, Elena Zamagni, Kazuyuki Shimizu, Sundar Jagannath, Hans Erik Johnsen, Evangelos Terpos, Tony Reiman, Robert A. Kyle, Pieter Sonneveld, Paul G. Richardson, Philip L. McCarthy, Heinz Ludwig, Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
Shaji Kumar, Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander, Avina K. Singh, Terri L. Parker, Alexander Menter, Xuezhong Yang, Benjamin M. Parsons, Pankaj Kumar, Prashant Kapoor, Aaron S. Rosenberg, Jeffrey A. Zonder, Edward A. Faber, Sagar Lonial, Kenneth C. Anderson, Paul G. Richardson, Robert Z. Orlowski, Lynne I. Wagner, S. Vincent Rajkumar
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
Antonio Palumbo, Orhan Sezer, Robert Kyle, Jesús F. San Miguel, Robert Z. Orlowski, Philippe Moreau, Rubén Niesvizky, Gareth J. Morgan, Raymond L. Comenzo, Pieter Sonneveld, Shaji Kumar, Roman Hájek, Sergio Giralt, Sara Bringhen, Kenneth Anderson, Paul G. Richardson, Michèle Cavo, Faith E. Davies, Joan Bladé, Hermann Einsele, Meletios Α. Dimopoulos, Andrew Spencer, Angela Dispenzieri, Tony Reiman, Kazuyuki Shimizu, J.H. Lee, Michel Attal, Mario Boccadoro, M.V. Mateos, Wei Chen, Heinz Ludwig, D. Joshua, Chor Sang Chim, Vânia Hungria, Ingemar Turesson, Brian Durie, Sagar Lonial, on behalf of the IMWG